0
0

Chapter 56. Treatment of Anxiety Disorders

Jonathan R. T. Davidson, M.D.; Kathryn M. Connor, M.D., M.H.S.; Wei Zhang, M.D., Ph.D.
DOI: 10.1176/appi.books.9781585623860.424275

Sections

Excerpt

Over the past decade and a half, there has been substantial progress in our understanding of the anxiety disorders. Particularly fruitful has been the search to develop new treatments for the six major anxiety disorders: obsessive-compulsive disorder (OCD), panic disorder, social phobia (social anxiety disorder), specific phobia, generalized anxiety disorder (GAD), and posttraumatic stress disorder (PTSD). In this chapter, we review the main findings from double-blind, and some open-label, trials in each disorder. Both short-term and continuation/maintenance treatment studies are included.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

References

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Which of the following medications has been approved by the U.S. Food and Drug Administration (FDA) to treat obsessive-compulsive disorder (OCD) in adults but not in children?
2.
A patient with severe symptoms of OCD has demonstrated a partial response to a selective serotonin reuptake inhibitor (SSRI). You decide to add another agent to the SSRI. In reviewing the literature, you conclude that the augmentation agent most likely to produce a beneficial result is
3.
You are treating a 72-year-old woman with panic disorder. A good first-line medication choice for this patient would be
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 3.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 12.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 2.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation